tiprankstipranks
Trending News
More News >
AptarGroup (ATR)
NYSE:ATR
US Market
Advertisement

AptarGroup (ATR) Earnings Dates, Call Summary & Reports

Compare
161 Followers

Earnings Data

Report Date
Feb 12, 2026
After Close (Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
1.24
Last Year’s EPS
1.52
Same Quarter Last Year
Moderate Buy
Based on 6 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Oct 30, 2025|
% Change Since:
|
Earnings Call Sentiment|Neutral
Aptar's earnings call presented a mixed outlook. The company highlighted growth in its Pharma segment, strategic acquisitions, and shareholder returns. However, challenges in the emergency medicine market and segments like Beauty and Closures, along with atypical litigation costs, were notable lowlights.
Company Guidance
During Aptar's 2025 Third Quarter Results Conference Call, the company reported adjusted earnings per share of $1.62, with a 6% increase in reported sales and 1% growth in core sales. The Pharma segment experienced a 2% core sales increase, driven by strong demand for proprietary drug delivery systems, particularly in central nervous system therapeutics and asthma treatments, alongside significant growth in injectables, up 18%. The Beauty segment saw flat core sales, offset by a decline in product sales, while the Closures segment reported a 1% decrease in core sales due to lower tooling sales and resin pricing pass-throughs. The company also highlighted its continued investment in innovation, with several product launches and strategic acquisitions, while maintaining a strong balance sheet with $265 million in cash and a leverage ratio of 1.22. Aptar plans to continue share repurchases and recently announced a 7% increase in its quarterly dividend to $0.48 per share.
Pharma Segment Growth
Pharma segment saw a core sales increase of 2%, driven by strong demand for dosing and dispensing technologies, especially in central nervous system applications, asthma, and COPD therapeutics. Injectables core sales increased 18%.
Strategic Acquisition in Brazil
Aptar signed an agreement to acquire Sommaplast, a Brazil-based provider of oral dosing pharma packaging solutions. This acquisition is expected to reinforce Aptar's footprint in Brazil and capitalize on growth in the oral dosing market.
Shareholder Returns
Aptar plans to continue returning capital to shareholders through share repurchases and increased dividends. 2025 has been a banner year for share repurchases, and the quarterly dividend was increased by nearly 7% to $0.48 per share.
Innovations and Approvals
Aptar's HeroTracker Sense technology received FDA 510(k) clearance. The company also inaugurated its expanded pharma research and development center in France, enhancing capabilities across its proprietary drug delivery business.

AptarGroup (ATR) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

ATR Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Feb 12, 2026
2025 (Q4)
1.24 / -
1.52
Oct 30, 2025
2025 (Q3)
1.57 / 1.62
1.498.72% (+0.13)
Jul 31, 2025
2025 (Q2)
1.59 / 1.66
1.3721.17% (+0.29)
May 01, 2025
2025 (Q1)
1.16 / 1.20
1.26-4.76% (-0.06)
Feb 06, 2025
2024 (Q4)
1.26 / 1.52
1.2125.62% (+0.31)
Oct 24, 2024
2024 (Q3)
1.42 / 1.49
1.397.19% (+0.10)
Jul 25, 2024
2024 (Q2)
1.36 / 1.37
1.2311.38% (+0.14)
Apr 25, 2024
2024 (Q1)
1.15 / 1.26
0.9532.63% (+0.31)
Feb 08, 2024
2023 (Q4)
1.12 / 1.21
0.9231.52% (+0.29)
Oct 25, 2023
2023 (Q3)
1.27 / 1.39
0.9546.32% (+0.44)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

ATR Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Oct 30, 2025
$124.36$116.01-6.71%
Jul 31, 2025
$156.56$140.83-10.05%
May 01, 2025
$147.32$151.02+2.51%
Feb 06, 2025
$154.97$141.83-8.48%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does AptarGroup (ATR) report earnings?
AptarGroup (ATR) is schdueled to report earning on Feb 12, 2026, After Close (Confirmed).
    What is AptarGroup (ATR) earnings time?
    AptarGroup (ATR) earnings time is at Feb 12, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is ATR EPS forecast?
          ATR EPS forecast for the fiscal quarter 2025 (Q4) is 1.24.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis